This scrip has fully corrected, bottomed out and has made a double bottom. Now it is poised to rise, as its USA sales have become stabilised with low prices of generic medicine acceptable to them. Buy and hold on for reaping good benefits.
NIFTY has made a triple top. at 8890. Normally, Triple top leads sure shot to surpass same and test higher levels. One has to patiently wait for NIFTY to cross 8964 and then 9114 in the coming few weeks or so. Trade in NIFTY with suitable stop loss, profiting regularly on every rise and entering as a buyer on every substantial fall. Adopt caution after 9114, with...